Medacta
At Medacta, we see a rising trend on the horizon: a truly personalized approach to knee replacement that may reduce pain while potentially improving outcomes. Reinforcing Medacta’s commitment to advancing KA principles via implant design, the panel discussed their experience with this surgical technique and introduced the GMK SpheriKA: the first KA-optimized femoral implant on the market.
Login to view comments.
Click here to Login
